Perceptive Advisors LLC 13D and 13G filings for CytomX Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 4:00 pm Purchase | 2026-03-31 | 13G | CYTOMX THERAPEUTICS INC CTMX | Perceptive Advisors LLC | 10,098,824 4.600% | 418,639 (+4.32%) | Filing |
| 2025-08-21 4:00 pm Purchase | 2025-08-14 | 13G | CYTOMX THERAPEUTICS INC CTMX | Perceptive Advisors LLC | 9,680,185 5.900% | 7,103,142 (+275.63%) | Filing |